VAXCHORA Pediatric Study to Assess Safety and Immunogenicity

Inclusion Criteria: * Male or Female * Between 2 and \<18 years of age on Day 1 * In general good health * Able and willing to provide informed assent for study participation * Primary caregiver is able and willing to provide informed consent for study participation * (for females of childbearing potential) Using an acceptable method of contraception through Day 29 Exclusion Criteria: * Current acute gastrointestinal illness or loose stools within 3 days of Day 1 visit * Current acute febrile illness * History of cholera infection * History of cholera vaccination * History of severe allergic reaction (e.g. anaphylaxis) to any ingredient of VAXCHORA * Congenital or acquired immunodeficiency * Pregnancy (for females of childbearing potential) * Any other condition that, in the opinion of the Investigator, creates an unacceptable risk to the subject * Any other condition that, in the opinion of the Investigator, will interfere with the conduct of the study or the validity of the data * Duration of \>2 weeks of abnormal stool pattern, defined as \<3 stools per week or \>2 stools per day in the past 6 months * Regular use of laxatives in the past 6 months * History of enterotoxigenic E. coli infection * Travel to cholera-endemic area in the previous 5 years * Nursing/Breastfeeding * Received or plans to receive the following from 14 days prior to the study vaccination through 11 days after vaccination: Any other licensed vaccines, antibiotics, or chloroquine * Received or plans…